Results 141 to 150 of about 3,757,153 (283)

Therapeutic effects of extracorporeal shock wave therapy on patients with spastic cerebral palsy and Rett syndrome: clinical and ultrasonographic findings

open access: yesOrphanet Journal of Rare Diseases
Background Extracorporeal shock wave therapy (ESWT) is reportedly effective for improving spasticity and motor function in children with cerebral palsy (CP). Because late-stage Rett syndrome has a similar presentation, this study aimed to investigate the
Ting-Yu Su   +5 more
doaj   +1 more source

Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes

open access: yesFrontiers in Drug Discovery
IntroductionRett Syndrome is a genetic neurodevelopmental disorder caused by decreased levels of MeCP2. Due to mutations in the MECP2 gene, insufficient MeCP2 protein levels lead to clinical phenotypes including the loss of normal movement, decreased ...
Joseph S. Anderson   +4 more
doaj   +1 more source

Whole exome sequencing reveals a de novo missense variant in EEF1A2 in a Rett syndrome‐like patient

open access: yesClinical Case Reports, 2019
Using whole exome sequencing, we found a pathogenic variant in the EEF1A2 gene in a patient with a Rett syndrome‐like (RTT‐like) phenotype, further confirming the association between EEF1A2 and Rett syndrome RTT and RTT‐like phenotypes.
Simranpreet Kaur   +7 more
doaj   +1 more source

The effectiveness of music therapy for individuals with Rett syndrome and their families

open access: yesJournal of the Formosan Medical Association, 2019
Background: Patients with Rett syndrome (RTT) present characteristic regression in communication and hand skills, which eventually leads to intellectual and physical disability. Moreover, caregivers of patients with RTT face stressors related to patients’
Ming-Yi Chou   +8 more
doaj   +1 more source

Genetic testing in paediatric neurological disorders

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In this study 390 paediatric patients with neurological disorders underwent genetic testing via exome sequencing, commercial panel, in‐house epilepsy, and movement disorder gene panels. Exome sequencing provides the highest diagnostic yield, and severe developmental delay and hypotonia predicted pathogenic variants in the exome sequencing cohort ...
Wafa Bani Uraba   +15 more
wiley   +1 more source

Rett Syndrome: Growth and Nutrition

open access: yes, 1992
Feeding problems, dietary intake and the growth and nutrition of 10 girls with Rett syndrome were reported from the University of Oslo ...
J Gordon Millichap
core   +1 more source

Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome

open access: yesNature Medicine, 2017
Mutations in MECP2 cause Rett syndrome (RTT), an X-linked neurological disorder characterized by regressive loss of neurodevelopmental milestones and acquired psychomotor deficits. However, the cellular heterogeneity of the brain impedes an understanding
Brian S. Johnson   +12 more
semanticscholar   +1 more source

Autism spectrum disorder assessment in cerebral palsy and other early‐onset motor conditions: A scoping review

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Abstract Aim To map diagnostic procedures and standardized instruments reportedly used to identify autism spectrum disorder (ASD) in people with cerebral palsy or other early‐onset motor conditions (EOMC) including Rett syndrome and muscular dystrophy.
Olga Laporta‐Hoyos   +11 more
wiley   +1 more source

Role of the International Rett Syndrome Association

open access: yes, 1988
Since 1984, the International Rett Syndrome Association has brought together families of girls with Rett syndrome, disseminated information about the syndrome, and supported research efforts.
Kathy Hunter
core   +1 more source

Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome

open access: yesAnnals of Clinical and Translational Neurology, 2018
To measure the efficacy of mecasermin (recombinant human insulin‐like growth factor 1, rhIGF‐1), for treating symptoms of Rett syndrome (RTT) in a pediatric population using a double‐blind crossover study design.
Heather M. O'Leary   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy